Calcium is involved in formation of high molecular weight adiponectin

Metabolic Syndrome and Related Disorders

Volumn 6, Issue 2, 2008, Pages 103-111

  Banga, Anannya ^a   Bodles, Angela M ^a   Rasouli, Neda ^a   Ranganathan, Gouri ^a   Kern, Philip A ^a   Owens, Randall J ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CALCIUM; EDETIC ACID; EGTAZIC ACID; MAGNESIUM;

ADIPOCYTE; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIMPSON GOLABI BEHMEL SYNDROME; WESTERN BLOTTING;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; BLOTTING, WESTERN; CALCIUM; CENTRIFUGATION, DENSITY GRADIENT; CHELATING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; PROTEIN ISOFORMS; SUCROSE;

EID: 44449098156     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2007.0033     Document Type: Article

References (40)

1. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004;116:337-350.
2. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005;257:167-175.
3. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
4. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003;52:1779-1785.
5. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 2001;7:941-946.
6. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004;279:12152-12162.
7. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T. Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 2003;278:40352-40363.
8. Wang Y, Xu LY, Lam KS, Lu G, Cooper GJ, Xu A. Proteomic characterization of human serum proteins associated with the fat-derived hormone adiponectin. Proteomics 2006;6:3862-3870.
9. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003;278:9073-9085.
10. Wang ZV, Schraw TD, Kim JY, Khan T, Rajala MW, Follenzi A, Scherer PE. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol 2007;27:3716-3731.
11. Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2004;89:4312-4319.
12. Bodles A, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ. Pioglitazone increases secretion of high molecular weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab 2006;291:E1100-E1105.
13. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003;4:517-529.
14. Leukert N, Vogl T, Strupat K, Reichelt R, Sorg C, Roth J. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J Mol Biol 2006;359:961-972.
15. Vogl T, Roth J, Sorg C, Hillenkamp F, Strupat K. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 1999;10:1124-1130.
16. Kern PA, Marshall S, Eckel RH. Regulation of lipoprotein lipase in primary cultures of isolated human adipocytes. J Clin Invest 1985;75:199-208.
17. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E, Debatin KM, Hauner H. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 2001;25:8-15.
18. Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ, III, McGehee RE, Jr., Fried SK, Kern PA. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipid and inflammation. J Clin Endocrinol Metab 2007;92:666-672.
19. Suzuki S, Wilson-Kubalek EM, Wert D, Tsao TS, Lee DH. The oligomeric structure of high molecular weight adiponectin. FEBS Lett 2007;581:809-814.
20. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006;55:249-259.
21. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, Heuser JE, Lodish HF. Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling Specificity: different oligomers activate different signal transduction pathways. J Biol Chem 2003;278:50810-50817.
22. Gaboriaud C, Juanhuix J, Gruez A, Lacroix M, Darnault C, Pignol D, Verger D, Fontecilla-Camps JC, Arlaud GJ. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 2003;278:46974-46982.
23. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology 1998;8:335-338.
24. Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 2004;53:1621-1629.
25. McPhalen CA, Strynadka NC, James MN. Calcium-binding sites in proteins: a structural perspective. Adv Protein Chem 1991;42:77-144.
26. Baumann U, Wu S, Flaherty KM, McKay DB. Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J 1993;12:3357-3364.
27. Kretsinger RH. Calcium-binding proteins. Annu Rev Biochem 1976;45:239-266.
28. Strynadka NC, James MN. Crystal structures of the helix-loop-helix calcium- binding proteins. Annu Rev Biochem 1989;58:951-998.
29. Lewit-Bentley A, Rety S. EF-hand calcium-binding proteins. Curr Opin Struct Biol 2000;10:637-643.
30. Rigden DJ, Galperin MY. The DxDxDG motif for calcium binding: multiple structural contexts and implications for evolution. J Mol Biol 2004;343:971-984.
31. Huq NL, Cross KJ, Reynolds EC. Nascent helix in the multiphosphorylated peptide alphaS2-casein(2-20). J Pept Sci 2003;9:386-392.
32. Chen B, Mayer MU, Markillie LM, Stenoien DL, Squier TC. Dynamic motion of helix A in the amino-terminal domain of calmodulin is stabilized upon calcium activation. Biochemistry 2005;44:905-914.
33. Sen A, Sen N, Mackow ER. The formation of viroplasm-like structures by the rotavirus NSP5 protein is calcium regulated and directed by a C-terminal helical domain. J Virol 2007;81:11758-11767.
34. Peake PW, Shen Y, Campbell LV, Charlesworth JA. Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun 2006;341:108-115.
35. Ruano ML, Garcia-Verdugo I, Miguel E, Perez-Gil J, Casals C. Self-aggregation of surfactant protein A. Biochemistry 2000;39:6529-6537.
36. Zik M, Fridmann-Sirkis Y, Fromm H. C-terminal residues of plant glutamate decarboxylase are required for oligomerization of a high-molecular weight complex and for activation by calcium/calmodulin. Biochim Biophys Acta 2006;1764:872-876.
37. Shi H, Halvorsen YD, Ellis PN, Wilkison WO, Zemel MB. Role of intracellular calcium in human adipocyte differentiation. Physiol Genomics 2000;3:75-82.
38. Zhang F, Sowers JR, Ram JL, Standley PR, Peuler JD. Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 1994;24:170-175.
39. Heppner TJ, Bonev AD, Eckman DM, Gomez MF, Petkov GV, Nelson MT. Novel PPARgamma agonists GI 262570, GW 7845, GW 1929, and pioglitazone decrease calcium channel function and myogenic tone in rat mesenteric arteries. Pharmacology 2005;73:15-22.
40. Bogan JS, Lodish HF. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol 1999;146:609-620.